Akers Biosciences is a provider of rapid diagnostic solutions. Co.'s commercialized product portfolio incorporates the following proprietary platform testing and sample preparation technologies: Particle Immuno-Filtration Assay, an immunoassay method based on the selective filtration of dyed microparticles coated with antigen or antibody; MicroParticle Catalyzed Biosensor, which permits the identification of medical conditions through biomarkers in exhaled breath; and Rapid Blood Cell Separation Technology, which increases the rate at which a test result is obtained as the often-required sample preparation step is abbreviated. We show 31 historical shares outstanding datapoints in our AKER shares outstanding history coverage, used to compute AKER market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AKER market cap history over the course of time is important for investors
interested in comparing AKER's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AKER versus a peer is one thing; comparing
AKER market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AKER can fluctuate over the course of history.
With this page we aim to empower investors researching AKER by allowing them to research the AKER market cap history. |
Video: The Importance of Market Cap
